Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Paul

Showing results (751-760 of 1,117) with videos related to

Pageof 112
Sort By:
Oncotarget|July 11, 2015
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)Pramudita R Prasetyanti, Emily Capone, Daniela Barcaroli, et al.
European Heart Journal|February 1, 2005
Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Arnoud W J van 't Hof, Jan Paul Ottervanger, et al.
European Heart Journal|February 10, 2009
Pressure-volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sitesPeter Paul H M Delnoy, Jan Paul Ottervanger, Henk Oude Luttikhuis, et al.
Coronary Artery Disease|December 4, 2008
Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarctionMark B Nienhuis, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2013
Immunostaining for rapid diagnosis of acute promyelocytic leukemia with the tetramethylrhodamine-5-isothiocyanate-conjugated anti-promyelocytic leukemia monoclonal antibody PG-M3Khaled M Alayed, L Jeffrey Medeiros, Danh Phan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?Jan-Henk E Dambrink, Jan P Debrauwere, Arnoud W J van 't Hof, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 27, 2021
[<sup>18</sup>F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinomaJoris L Vos, Charlotte L Zuur, Laura A Smit, et al.
Coronary Artery Disease|August 4, 2011
Predictors and importance of prolonged hospital stay after primary PCI for ST elevation myocardial infarctionDirk A A M Schellings, Jan Paul Ottervanger, Arnoud W J van 't Hof, et al.
The American Journal of Cardiology|September 20, 2005
Impact of beta-blocker therapy at discharge on long-term mortality after primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Menko-Jan de Boer, Jan Paul Ottervanger, et al.
International Urogynecology Journal|July 20, 2017
The effectiveness of mediolateral episiotomy in preventing obstetric anal sphincter injuries during operative vaginal delivery: a ten-year analysis of a national registryJeroen van Bavel, Chantal W P M Hukkelhoven, Charlotte de Vries, et al.
Pageof 112

Showing results (751-760 of 1,117) with videos related to

Sort By:
Pageof 112
Oncotarget|July 11, 2015
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)Pramudita R Prasetyanti, Emily Capone, Daniela Barcaroli, et al.
European Heart Journal|February 1, 2005
Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Arnoud W J van 't Hof, Jan Paul Ottervanger, et al.
European Heart Journal|February 10, 2009
Pressure-volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sitesPeter Paul H M Delnoy, Jan Paul Ottervanger, Henk Oude Luttikhuis, et al.
Coronary Artery Disease|December 4, 2008
Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarctionMark B Nienhuis, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2013
Immunostaining for rapid diagnosis of acute promyelocytic leukemia with the tetramethylrhodamine-5-isothiocyanate-conjugated anti-promyelocytic leukemia monoclonal antibody PG-M3Khaled M Alayed, L Jeffrey Medeiros, Danh Phan, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?Jan-Henk E Dambrink, Jan P Debrauwere, Arnoud W J van 't Hof, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 27, 2021
[<sup>18</sup>F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinomaJoris L Vos, Charlotte L Zuur, Laura A Smit, et al.
Coronary Artery Disease|August 4, 2011
Predictors and importance of prolonged hospital stay after primary PCI for ST elevation myocardial infarctionDirk A A M Schellings, Jan Paul Ottervanger, Arnoud W J van 't Hof, et al.
The American Journal of Cardiology|September 20, 2005
Impact of beta-blocker therapy at discharge on long-term mortality after primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Menko-Jan de Boer, Jan Paul Ottervanger, et al.
International Urogynecology Journal|July 20, 2017
The effectiveness of mediolateral episiotomy in preventing obstetric anal sphincter injuries during operative vaginal delivery: a ten-year analysis of a national registryJeroen van Bavel, Chantal W P M Hukkelhoven, Charlotte de Vries, et al.
Pageof 112